🔗 Share this article

Chancellor Reeves has stated she is preparing "targeted measures to address household expense issues" in the upcoming financial statement.

During an interview with the BBC, she noted that curbing price rises is a joint responsibility of both the government and the Bank of England.

The United Kingdom's inflation rate is projected to be the most elevated among the G7 industrialized countries this calendar year and the following year.

Possible Utility Bill Measures

Sources suggest the government could take action to lower utility costs, for instance by reducing the present 5% rate of value-added tax charged on energy.

An additional possibility is to reduce some of the regulatory levies currently included in household expenses.

Fiscal Constraints and Expert Predictions

The administration will receive the next assessment from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much scope there is for such measures.

The expectation from the majority of economists is that the Chancellor will have to declare tax increases or expenditure reductions in order to meet her self-imposed fiscal targets.

Previously on Thursday, calculations showed there was a £22bn gap for the chancellor to resolve, which is at the lower end of expectations.

"There's a joint task between the central bank and the government to further reduce some of the causes of price increases," the Chancellor stated to reporters in the US capital, at the conferences of the International Monetary Fund and global financial institution.

Tax Commitments and Global Concerns

While a great deal of the attention has been on likely tax increases, the Treasury chief said the latest figures from the OBR had not changed her commitment to election pledges not to increase tax levels on earnings tax, sales tax or National Insurance.

She attributed an "unpredictable world" with rising geopolitical and trade concerns for the fiscal revenue measures, probably to be focused on those "most able to pay."

Global Trade Tensions

Addressing worries about the United Kingdom's economic relations with the Asian nation she said: "Our security interests always come first."

Last week's statement by Chinese authorities to tighten trade restrictions on critical minerals and other materials that are essential for advanced tech manufacturing led American leader Donald Trump to suggest an additional 100% import tax on imports from China, increasing the prospect of an all-out trade war between the two economic giants.

The US Treasury Secretary called China's move "economic coercion" and "a global supply chain power grab."

Inquired about accepting the American proposal to join its battle with the Asian nation, the Chancellor said she was "very concerned" by China's measures and encouraged the Chinese government "not to put up barriers and limit trade."

She said the action was "bad for the world economy and generates additional headwinds."

"It is my opinion there are areas where we must confront Chinese policies, but there are also important prospects to export to China's economy, including financial services and other sectors of the economy. We've got to achieve that balance appropriate."

The chancellor also affirmed she was collaborating with G7 counterparts "regarding our own critical minerals plan, so that we are less reliant."

Health Service Medicine Pricing and Investment

Reeves also recognized that the price the National Health Service spends on drugs could increase as a consequence of current negotiations with the Trump administration and its pharmaceutical firms, in return for reduced taxes and investment.

Some of the biggest global pharmaceutical manufacturers have said lately that they are either delaying or canceling operations in the UK, with several attributing the low prices they are getting.

Last month, the government science advisor said the cost the NHS pays for drugs would must rise to prevent companies and pharmaceutical investment departing from the UK.

The Chancellor told media: "It has been observed as a result of the pricing regime, that drug testing, innovative medicines have not been available in the UK in the manner that they are in other continental states."

"The objective is to guarantee that people receiving treatment from the NHS are can access the finest essential treatments in the world. And so we are looking at all of that, and... looking to secure increased funding into the UK."